Correlation Between Structure Therapeutics and Regenxbio
Can any of the company-specific risk be diversified away by investing in both Structure Therapeutics and Regenxbio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Structure Therapeutics and Regenxbio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Structure Therapeutics American and Regenxbio, you can compare the effects of market volatilities on Structure Therapeutics and Regenxbio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Structure Therapeutics with a short position of Regenxbio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Structure Therapeutics and Regenxbio.
Diversification Opportunities for Structure Therapeutics and Regenxbio
0.76 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Structure and Regenxbio is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding Structure Therapeutics America and Regenxbio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Regenxbio and Structure Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Structure Therapeutics American are associated (or correlated) with Regenxbio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Regenxbio has no effect on the direction of Structure Therapeutics i.e., Structure Therapeutics and Regenxbio go up and down completely randomly.
Pair Corralation between Structure Therapeutics and Regenxbio
Given the investment horizon of 90 days Structure Therapeutics American is expected to generate 0.74 times more return on investment than Regenxbio. However, Structure Therapeutics American is 1.36 times less risky than Regenxbio. It trades about 0.14 of its potential returns per unit of risk. Regenxbio is currently generating about 0.03 per unit of risk. If you would invest 2,819 in Structure Therapeutics American on November 2, 2024 and sell it today you would earn a total of 213.00 from holding Structure Therapeutics American or generate 7.56% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Structure Therapeutics America vs. Regenxbio
Performance |
| Timeline |
| Structure Therapeutics |
| Regenxbio |
Structure Therapeutics and Regenxbio Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Structure Therapeutics and Regenxbio
The main advantage of trading using opposite Structure Therapeutics and Regenxbio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Structure Therapeutics position performs unexpectedly, Regenxbio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regenxbio will offset losses from the drop in Regenxbio's long position.| Structure Therapeutics vs. Day One Biopharmaceuticals | Structure Therapeutics vs. X4 Pharmaceuticals | Structure Therapeutics vs. Inozyme Pharma | Structure Therapeutics vs. Acumen Pharmaceuticals |
| Regenxbio vs. Day One Biopharmaceuticals | Regenxbio vs. Replimune Group | Regenxbio vs. Mirum Pharmaceuticals | Regenxbio vs. Rocket Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Complementary Tools
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |